Gifu, Japan

Kenji Ichihara

This inventor holds 1 USPTO granted patent. Top assignee: Maruko Seiyaku Co., Ltd.. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Ichihara. Retrieved from https://idiyas.com/inventor/kenji-ichihara-66j37aow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenji Ichihara: Innovator in Ergoline Derivatives

Introduction

Kenji Ichihara is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ergoline derivatives. His research focuses on developing compounds that have a wide range of therapeutic applications.

Latest Patents

Ichihara holds a patent for "Ergoline derivatives and acid addition salts thereof." This patent discloses novel ergoline derivatives that exhibit excellent anti-hypertensive activity, vasodilating activity, anti-ulcer activity, gastric secretion inhibitory activity, brain metabolism improving activity, anti-depressive activity, and dopamine-like activity. These properties make the compounds useful for the prevention and treatment of various diseases, including hypertension, a variety of vein disorders, peptic ulcers, brain abnormalities, depression, Parkinson's disease, and high prolactin blood disease. He has 1 patent to his name.

Career Highlights

Ichihara is associated with Maruko Seiyaku Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in pushing the boundaries of pharmaceutical science, particularly in the area of cardiovascular and neurological health.

Collaborations

Some of his notable coworkers include Sachio Ohno and Takao Ban. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Kenji Ichihara's innovative work in the field of ergoline derivatives showcases his commitment to improving health outcomes through scientific research. His contributions are paving the way for new treatments for complex medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…